1. Home
  2. TCBX vs CTMX Comparison

TCBX vs CTMX Comparison

Compare TCBX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Third Coast Bancshares Inc.

TCBX

Third Coast Bancshares Inc.

HOLD

Current Price

$40.44

Market Cap

716.7M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.06

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBX
CTMX
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.7M
596.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
TCBX
CTMX
Price
$40.44
$5.06
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$42.33
$8.86
AVG Volume (30 Days)
58.8K
2.7M
Earning Date
04-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
40.40
N/A
EPS
2.77
N/A
Revenue
N/A
$138,103,000.00
Revenue This Year
$29.99
N/A
Revenue Next Year
$10.14
N/A
P/E Ratio
$14.35
$22.58
Revenue Growth
N/A
36.45
52 Week Low
$25.17
$0.40
52 Week High
$43.84
$6.35

Technical Indicators

Market Signals
Indicator
TCBX
CTMX
Relative Strength Index (RSI) 46.70 44.70
Support Level $39.16 $3.83
Resistance Level $42.92 $6.20
Average True Range (ATR) 1.34 0.33
MACD -0.29 -0.10
Stochastic Oscillator 29.89 16.54

Price Performance

Historical Comparison
TCBX
CTMX

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: